No Picture
Trading Ideas

UPDATE 1-Higher Bakken output helps Hess post smaller loss, raise production view

Hess Corp reported a smaller-than-expected quarterly loss and raised its full-year production forecast on Wednesday, owing to higher output at the U.S. oil and gas producer’s assets in the Bakken shale. Production from Bakken rose 38% to 163,000 barrels of oil equivalent per day (boe/d) in the quarter, helping net production, excluding Libya, rise about 4% to 290,000 boe/d. Oil from seven big shale formations, particularly the Permian basin of Texas and New Mexico and the Bakken in North Dakota, have helped the United States become the biggest crude oil producer in the world. …read more […]

No Picture
Trading Ideas

UPDATE 1-FDA approves Biogen and Alkermes' multiple sclerosis drug

The U.S. Food and Drug Administration approved Biogen Inc and partner Alkermes Plc’s oral drug to treat multiple sclerosis, the companies said on Wednesday. The approval is good news for Biogen as its top-selling drug Tecfidera, also a multiple sclerosis treatment, is facing patent challenges and increased competition from newer treatments such as Roche AG’s Ocrevus. The new drug, Vumerity, was approved to treat relapsing forms of multiple sclerosis, a disabling autoimmune disease that damages the central nervous system and can lead to fatigue, pain, vision loss and impaired coordination and motor skills. …read more […]

No Picture
Trading Ideas

Beyond Meat Sinks On End Of Lock-Up

Wall Street was generally bullish on Beyond Meat (BYND) after the alternative meat producer released news of a much bigger profit than expected, but analysts cautioned that the fundamentals may not matter right now despite the company’s once furious upward trajectory, as insiders may intervene. …read more […]

No Picture
Business News

Apple CEO’s handling of trade war has helped buoy shares, investors say

When Apple Inc reports results on Wednesday, Wall Street expects flat fiscal fourth-quarter sales and lower full-year revenue compared with the prior year, mostly because of declining iPhone sales. Yet Apple’s stock price has hit all-time highs in recent weeks, as has its price-to-earnings valuation.

…read more […]